Form 4 for NTRA Natera, Inc.
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-28 · accession 0001415889-25-020663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-30 | 2025-07-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $139.81 | -2,206 | 126.1K | -2% | -$308.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-28 | S | D | 2,206 | $139.81 | 126,059 | D | — | — | (F1) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023 and January 26, 2024. |